Table 2 Association of HNF1B expression and clinicopathological characteristics, based on 93 cases of ccRCC.

From: Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours

Characteristic

Group

N

H-score mean

H-score median

p-valuea

Categorized H-score

Group 1

Group 2

Group 3

p-valueb

Gender

    

0.617

   

0.399

 

Male

54

198.2

240

 

12

13

29

 
 

Female

39

205.8

250

 

10

5

24

 

Age (mean = 63, median = 65)

    

0.849

   

0.414

 

˂ 65

44

198.9

240

 

8

8

28

 
 

 ≥ 65

49

203.5

260

 

14

10

25

 

pT classification

    

0.094

   

0.360

 

pT1

70

212.4

265

 

15

11

44

 
 

pT2

6

141.7

145

 

2

2

2

 
 

pT3

17

177.1

170

 

5

5

7

 

Grade

    

0.002

   

0.012

 

G1

22

255.5

300

 

2

2

18

 
 

G2

53

196.1

240

 

14

9

30

 
 

G3

13

167.7

170

 

3

6

4

 
 

G4

5

106.0

50

 

3

1

1

 

Lymphovascular invasion*

    

0.264

   

0.558

 

Yes

15

177.3

200

 

5

3

7

 
 

No

75

207.1

260

 

16

14

45

 

Metastasis*

    

0.121

   

0.135

 

Yes

10

158.0

140

 

3

4

3

 
 

No

81

207.8

250

 

18

14

49

 

Recurrence*

    

0.458

   

0.899

 

Yes

8

183.8

210

 

2

2

4

 
 

No

83

204.1

250

 

19

16

48

 

rs4430796*

    

0.727

   

0.951

 

Yes

31

207.7

270

 

6

2

21

 
 

No

8

276.3

295

 

0

1

5

 

rs757210*

    

0.384

   

0.528

 

Yes

36

216.1

275

 

0

0

3

 
 

No

3

290.0

290

 

6

3

23

 
  1. Statistically significant results (p-value < 0.05) are highlighted in bold.
  2. ap values are based on Mann–Whitney U-test or Kruskal–Wallis H-test.
  3. bp values are based on Pearson chi-squared test (categorized expression).
  4. *Data are not available for all cases.